Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This gene entry, "novel atrophin-1 superfamily protein pseudogene" (ENSG00000285228), encodes a pseudogene related in sequence to the atrophin-1 superfamily of proteins but does not produce a functional protein. Pseudogenes are genomic elements that usually arise from duplication or retrotransposition events and have lost coding potential due to disabling mutations. Most pseudogenes, including this one, are considered non-functional "genomic fossils," although growing evidence suggests that some pseudogenes may exert regulatory roles at the RNA level, potentially via small RNA production or acting as competitive endogenous RNAs (ceRNAs). However, there is no evidence that this specific pseudogene is functional, relevant to disease, or serves as a drug target. Therefore, it is not considered a therapeutic target, and there is nothing to suggest it encodes a receptor, transporter, enzyme, or structurally relevant molecule for pharmacology. Key points: - This entry is a pseudogene, not a true protein-coding gene or therapeutic target. - There is no evidence it has a functional role or druggability. - It is incorrect to categorize it as a receptor or target for drugs based on current understanding of its nature and the available data.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on novel atrophin-1 superfamily protein pseudogene.